Literature DB >> 32960654

Validity of administrative codes associated with cirrhosis in Sweden.

Bonnie Bengtsson1,2, Johan Askling3,4, Jonas F Ludvigsson5,6,7,8, Hannes Hagström1,2,4.   

Abstract

OBJECTIVES: Although cirrhosisis a major cause of liver-related mortality globally, validation studies of the administrative coding for diagnoses associated with cirrhosis are scarce. We aimed to determine the validity of the International Classification of Diseases, 10th revision (ICD-10) codes corresponding to cirrhosis and its complications in the Swedish National Patient Register (NPR).
METHODS: We randomly selected 750 patients with ICD codes for either alcohol-related cirrhosis (K70.3), unspecified cirrhosis (K74.6) oesophageal varices (I85.0/I85.9), hepatocellular carcinoma (HCC, C22.0) or ascites (R18.9) registered in the NPR from 72 healthcare centres in 2000-2016. Hospitalisation events and outpatient visits in specialised care were included. Positive predictive values (PPVs) were calculated using the information in the patient charts as the gold standard.
RESULTS: Complete data were obtained for 630 (of 750) patients (84%). For alcohol-related cirrhosis, 126/136 cases were correctly coded, corresponding to a PPV of 93% (95% confidence interval, 95%CI: 87-96). The PPV for cirrhosis with unspecified aetiology was 91% (121/133, 95%CI: 85-95) and 96% for oesophageal varices (118/123, 95%CI: 91-99). The PPV was lower for HCC, 84% (91/109, 95%CI: 75-90). The PPV for liver-related ascites was low, 43% (56/129, 95%CI: 35-52), as this category often consisted of non-hepatic ascites. When combining the ascites code with a code for chronic liver disease, the PPV for liver-related ascites increased to 93% (50/54, 95%CI: 82-98).
CONCLUSIONS: The validity of ICD-10 codes for cirrhosis, oesophageal varices and HCC is high. However, coding for ascites should be combined with a code of chronic liver disease to have an acceptable validity.

Entities:  

Keywords:  Cirrhosis; ICD-10; ascites; epidemiology; hepatocellular carcinoma; oesophageal varices; validation

Year:  2020        PMID: 32960654     DOI: 10.1080/00365521.2020.1820566

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  11 in total

1.  The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population-based cohort study.

Authors:  Bonnie Bengtsson; Linnea Widman; Staffan Wahlin; Per Stål; Niklas K Björkström; Hannes Hagström
Journal:  United European Gastroenterol J       Date:  2022-05-01       Impact factor: 6.866

2.  Applying Administrative Data-Based Coding Algorithms for Frailty in Patients With Cirrhosis.

Authors:  Jeremy Louissaint; Susan L Murphy; Christopher J Sonnenday; Anna S Lok; Elliot B Tapper
Journal:  Liver Transpl       Date:  2021-07-31       Impact factor: 5.799

3.  Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement.

Authors:  Hannes Hagström; Leon A Adams; Alina M Allen; Christopher D Byrne; Yoosoo Chang; Henning Grønbaek; Mona Ismail; Peter Jepsen; Fasiha Kanwal; Jennifer Kramer; Jeffrey V Lazarus; Michelle T Long; Rohit Loomba; Philip N Newsome; Ian A Rowe; Seungho Ryu; Jörn M Schattenberg; Marina Serper; Nick Sheron; Tracey G Simon; Elliot B Tapper; Sarah Wild; Vincent Wai-Sun Wong; Yusuf Yilmaz; Shira Zelber-Sagi; Fredrik Åberg
Journal:  Hepatology       Date:  2021-06-22       Impact factor: 17.298

Review 4.  The Use of Administrative Data to Investigate the Population Burden of Hepatic Encephalopathy.

Authors:  Patricia P Bloom; Elliot B Tapper
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241

5.  Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM.

Authors:  Patricia C Valery; Elizabeth E Powell; Kelly Lee Hayward; Amy L Johnson; Leigh U Horsfall; Chris Moser
Journal:  BMJ Open Gastroenterol       Date:  2021-02

6.  Risk of infections and their role on subsequent mortality in biopsy-proven alcohol-related liver disease.

Authors:  Hannes Hagström; Maja Thiele; Tracey G Simon; Rajani Sharma; Anna Röckert Tjernberg; Bjorn Roelstraete; Jonas Söderling; Jonas F Ludvigsson
Journal:  United European Gastroenterol J       Date:  2022-01-28       Impact factor: 4.623

Review 7.  Systematic review: development of a consensus code set to identify cirrhosis in electronic health records.

Authors:  Jessica E Shearer; Juan J Gonzalez; Thazin Min; Richard Parker; Rebecca Jones; Grace L Su; Elliot B Tapper; Ian A Rowe
Journal:  Aliment Pharmacol Ther       Date:  2022-02-15       Impact factor: 9.524

8.  Risk of hepatic and extrahepatic cancer in NAFLD: A population-based cohort study.

Authors:  Karl Björkström; Linnea Widman; Hannes Hagström
Journal:  Liver Int       Date:  2022-02-24       Impact factor: 8.754

9.  Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.

Authors:  Tracey G Simon; Elisabetta Patorno; Sebastian Schneeweiss
Journal:  Clin Gastroenterol Hepatol       Date:  2021-07-10       Impact factor: 13.576

10.  Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.

Authors:  Mattias Lissing; Daphne Vassiliou; Ylva Floderus; Pauline Harper; Matteo Bottai; Marianna Kotopouli; Hannes Hagström; Eliane Sardh; Staffan Wahlin
Journal:  J Intern Med       Date:  2022-03-02       Impact factor: 13.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.